Literature DB >> 31262764

Effects of Delayed Antibiotic Therapy on Outcomes in Children with Streptococcus pneumoniae Sepsis.

Qinyuan Li1,2, Jie Cheng1,2, Yi Wu1,2, Zhili Wang1,2, Siying Luo1,2, Yuanyuan Li1,2, Xiaoyin Tian3, Guangli Zhang3, Dapeng Chen4, Zhengxiu Luo5.   

Abstract

Delayed antimicrobial therapy is associated with poor outcomes in sepsis, but the optimal antibiotic administration time remains unclear. We aimed to investigate the effects of the time of antimicrobial administration on outcomes and evaluate an optimal empirical antibiotic administration time window for children with Streptococcus pneumoniae sepsis. This retrospective study enrolled children with S. pneumoniae sepsis who presented to the Children's Hospital of Chongqing Medical University from May 2011 to December 2018. Classification and regression tree (CART) analysis was used to determine the time-to-appropriate-therapy (TTAT) breakpoint. Outcomes were compared between patients receiving early or delayed therapy, defined by CART-derived TTAT breakpoint. During the study period, 172 patients were included. The CART-derived TTAT breakpoint was 13.6 h. After adjustment for confounding factors, a TTAT of ≥13.6 hours was found to be an independent predictor of sepsis-related in-hospital mortality (odds ratio [OR] = 39.26; 95% confidence interval [CI] = 6.10 to 252.60), septic shock (OR = 4.58; 95% CI = 1.89 to 11.14), and requiring mechanical ventilation (OR = 2.70; 95% CI = 1.01 to 7.35). A Pediatric Risk of Mortality (PRISM) III score of ≥10 was independently associated with delayed therapy. Delayed antibiotic therapy was associated with poor outcomes in children with S. pneumoniae sepsis. The optimal empirical antibiotic administration time window in children with S. pneumoniae sepsis was within 13.6 h. Efforts should be made to ensure timely and appropriate therapy.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  Streptococcus pneumoniaezzm321990; children; delayed therapy; sepsis; time to appropriate therapy

Year:  2019        PMID: 31262764      PMCID: PMC6709508          DOI: 10.1128/AAC.00623-19

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  4 in total

1.  The transition between acute and chronic infections in light of energy control: a mathematical model of energy flow in response to infection.

Authors:  Gang Zhao; Rainer H Straub; Michael Meyer-Hermann
Journal:  J R Soc Interface       Date:  2022-06-22       Impact factor: 4.293

2.  Baseline kidney function is associated with vancomycin-induced acute kidney injury in children: a prospective nested case-control study.

Authors:  Huanian Zhang; Ping Gao; Yang Wang; Jianzhong Chen; Guangwei Jia; Furong Zhang; Fang Tao; Shiying Yuan
Journal:  Pediatr Nephrol       Date:  2020-11-07       Impact factor: 3.714

3.  The application value of metagenomic next-generation sequencing in children with invasive pneumococcal disease.

Authors:  Fang Guo; Lei Kang; Meixian Xu
Journal:  Transl Pediatr       Date:  2021-12

4.  Time to appropriate antimicrobial therapy serves an independent prognostic indicator in children with nosocomial Klebsiella pneumoniae bloodstream infection.

Authors:  Jie Cheng; Qinyuan Li; Guangli Zhang; Huiting Xu; Yuanyuan Li; Xiaoyin Tian; Dapeng Chen; Zhengxiu Luo
Journal:  BMC Pediatr       Date:  2022-10-03       Impact factor: 2.567

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.